Immediate Impact
1 from Science/Nature 69 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Adipokines: masterminds of metabolic inflammation
2024 Standout
Works of Bryant Harbourne being referenced
Abstract 1005: The bispecific antibody zanidatamab's (ZW25's) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers
2021
IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bryant Harbourne | 91 | 80 | 10 | 75 | 6 | 184 | |
| Marina Roy-Luzarraga | 115 | 95 | 9 | 67 | 6 | 219 | |
| Hongyan Huang | 114 | 119 | 8 | 114 | 8 | 249 | |
| Gürkan Mollaoglu | 87 | 87 | 7 | 53 | 5 | 196 | |
| Tomás A. Martins | 84 | 66 | 6 | 63 | 7 | 182 | |
| Thomas van Ee | 142 | 76 | 16 | 141 | 8 | 218 | |
| Sophie Léon | 89 | 59 | 4 | 51 | 4 | 155 | |
| Salah Almokadem | 65 | 72 | 11 | 36 | 9 | 148 | |
| Marnix Geukes Foppen | 96 | 126 | 23 | 79 | 8 | 184 | |
| Jens Nolting | 78 | 39 | 5 | 104 | 8 | 205 | |
| Carlos Gomez-Roca | 61 | 79 | 16 | 57 | 4 | 143 |
All Works
Login with ORCID to disown or claim papers
Loading papers...